Viewing Study NCT05088460


Ignite Creation Date: 2025-12-25 @ 2:14 AM
Ignite Modification Date: 2025-12-26 @ 12:43 AM
Study NCT ID: NCT05088460
Status: TERMINATED
Last Update Posted: 2025-10-16
First Post: 2021-10-12
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)
Sponsor: Regeneron Pharmaceuticals
Organization: